135 related articles for article (PubMed ID: 363434)
1. A comparison of slow release oxprenolol with conventional oxprenolol in the treatment of hypertension.
Resnekov EB; Havard CW
Eur J Clin Pharmacol; 1978 Nov; 14(2):77-81. PubMed ID: 363434
[TBL] [Abstract][Full Text] [Related]
2. Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily.
Müller FB; Allsopp LF; Cooper GL; Bolli P; Frei P; Glaus L; Ritz R; Bühler FR
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):207S-212S. PubMed ID: 4005124
[TBL] [Abstract][Full Text] [Related]
3. Experience with a slow-release formulation of oxprenolol.
Waal-Manning HJ; Spears GF
N Z Med J; 1978 Apr; 87(609):245-6. PubMed ID: 275650
[TBL] [Abstract][Full Text] [Related]
4. Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily.
Olowoyeye JO; Thadani U; Parker JO
Am J Cardiol; 1981 May; 47(5):1123-7. PubMed ID: 7223659
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the effects of the slow release formulations of metoprolol and oxprenolol in hypertension.
Comerford MB; Besterman EM
Ann Clin Res; 1982 Feb; 14(1):27-31. PubMed ID: 7137874
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a slow-release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension.
O'Brien KP; Stephens EJ
Clin Sci Mol Med Suppl; 1976 Dec; 3():559s-561s. PubMed ID: 1071681
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of two oxprenolol oral osmotic (OROS) delivery systems in patients with essential hypertension.
McInnes GT; Brodie MJ
Eur J Clin Pharmacol; 1988; 34(6):605-11. PubMed ID: 3169112
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical effects of propranolol (Inderal) with once daily slow-release oxprenolol (Slow Trasicor) in angina pectoris.
Majid PA; de Feijter PJ; Wardeh R; van der Wall EE; Roos JP
J Int Med Res; 1979; 7(3):194-200. PubMed ID: 378729
[TBL] [Abstract][Full Text] [Related]
9. Comparison of oxprenolol and methyldopa in hypertension. A within-patient double-blind trial.
Barritt DW; Marshall AJ; Heaton S
Lancet; 1976 Mar; 1(7958):503-5. PubMed ID: 55780
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension.
Wilcox RG; Hampton JR
Br Heart J; 1981 Nov; 46(5):498-502. PubMed ID: 6119103
[TBL] [Abstract][Full Text] [Related]
11. Once daily beta-blocker in hypertension--oxprenolol slow-release.
Gordon RD; Ziesak M; Rowe WS; Strakosch CR; Row G
J Int Med Res; 1981; 9(1):6-11. PubMed ID: 7009256
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a slow release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension.
O'Brien KP; Stephens EJ
N Z Med J; 1976 Aug; 84(570):142-4. PubMed ID: 1069924
[TBL] [Abstract][Full Text] [Related]
13. Slow-release oxprenolol compared with oxprenolol in hypertensive patients: a multicenter clinical trial.
Materson BJ; Friedman BA; Hla KM; Neidorf BS; Gray JM; Glazer N; Gross S
Drug Intell Clin Pharm; 1983 Jan; 17(1):51-4. PubMed ID: 6337801
[TBL] [Abstract][Full Text] [Related]
14. A comparison of slow release with conventional oxprenolol: plasma concentrations and clinical effects.
West MJ; Kendall MJ; Mitchard M; Faragher EB
Br J Clin Pharmacol; 1976 Jun; 3(3):439-43. PubMed ID: 788749
[TBL] [Abstract][Full Text] [Related]
15. A double-blind study of oxprenolol once and twice daily in hypertensive patients.
Glazer N; Friedman B; Gerlings E; Gross S; Lowney C; Solomon R
Clin Cardiol; 1983 Aug; 6(8):378-83. PubMed ID: 6352119
[TBL] [Abstract][Full Text] [Related]
16. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
Ravid M; Lang R; Jutrin I
Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris.
Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB
Eur J Clin Pharmacol; 1987; 32(2):127-33. PubMed ID: 3556193
[TBL] [Abstract][Full Text] [Related]
18. A multicentre evaluation of sustained release oxprenolol in the management of hypertension in hospital out-patient practice.
Forrest WA
J Int Med Res; 1978; 6(2):136-40. PubMed ID: 631415
[TBL] [Abstract][Full Text] [Related]
19. Can once daily dosage be effective in the treatment of hypertension throughout 24 hours? A controlled evaluation of sustained release oxprenolol.
Volan GN; Rogers HJ; House F
Br J Clin Pharmacol; 1979 Jul; 8(1):86-9. PubMed ID: 399593
[No Abstract] [Full Text] [Related]
20. Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension.
Petrie JC; Jeffers TA; Robb OJ; Scott AK; Webster J
Br Med J; 1980 Jun; 280(6231):1573-4. PubMed ID: 7000243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
